MitoExtra reformulation of mitomycin C: SUPG began a safety and equivalency trial with MitoExtra.

SuperGen Inc. (SUPG), Emeryville, Calif. Product: MitoExtra reformulation of mitomycin C Indication: Cancer Status: SUPG began a safety and equivalency trial with MitoExtra. The reformulation is desig...